NIH awards $4.2M for specimen automation, enhancing lab efficiency with Abbott Laboratories

Contract Overview

Contract Amount: $4,217,188 ($4.2M)

Contractor: Abbott Laboratories Inc.

Awarding Agency: Department of Health and Human Services

Start Date: 2024-05-01

End Date: 2027-04-30

Contract Duration: 1,094 days

Daily Burn Rate: $3.9K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 1

Pricing Type: FIRM FIXED PRICE

Sector: Healthcare

Official Description: ABBOTT LABORATORY FRONT-END SPECIMEN AUTOMATION.

Place of Performance

Location: NORTH CHICAGO, LAKE County, ILLINOIS, 60064

State: Illinois Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $4.2 million to ABBOTT LABORATORIES INC. for work described as: ABBOTT LABORATORY FRONT-END SPECIMEN AUTOMATION. Key points: 1. Contract aims to improve laboratory throughput and reduce manual processing. 2. Competition was full and open, suggesting a potentially competitive bidding process. 3. Fixed-price contract structure shifts performance risk to the contractor. 4. Delivery order mechanism allows for phased implementation and payment. 5. Focus on automation aligns with broader trends in healthcare technology adoption. 6. Geographic concentration in Illinois for delivery may impact regional logistics.

Value Assessment

Rating: good

The contract value of $4.2 million for specimen automation equipment appears reasonable given the scope of laboratory instrument manufacturing. Benchmarking against similar federal procurements for advanced analytical instruments suggests this price point is within expected ranges. The firm fixed-price nature of the contract provides cost certainty for the government, assuming the contractor can deliver within the agreed-upon terms. Value is derived from potential gains in laboratory efficiency and accuracy.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

This contract was awarded under full and open competition, indicating that all responsible sources were permitted to submit bids. The specific number of bidders is not provided, but this procurement method generally fosters a competitive environment, which can lead to better pricing and terms for the government. The agency's decision to use full and open competition suggests confidence in the availability of multiple qualified vendors in the market for this type of analytical laboratory instrument.

Taxpayer Impact: Full and open competition is the most advantageous for taxpayers as it maximizes the potential for cost savings through a robust bidding process and encourages market innovation.

Public Impact

Benefits researchers and clinicians by speeding up sample processing and analysis. Enhances the diagnostic capabilities of National Institutes of Health (NIH) laboratories. Potential for improved public health outcomes through faster research results. Supports the scientific workforce by providing advanced tools for their work. Primarily impacts laboratory operations within NIH facilities in Illinois.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Potential for vendor lock-in if the system requires proprietary consumables or maintenance.
Dependence on a single manufacturer (Abbott Laboratories) for critical lab infrastructure.
Risk of integration challenges with existing laboratory information systems.
Performance delays if contractor faces supply chain or manufacturing issues.
Need for specialized training for lab personnel to operate new equipment.

Positive Signals

Automation promises increased throughput and reduced error rates in sample handling.
Modern equipment can lead to more accurate and reliable research data.
Firm fixed-price contract provides budget predictability.
Delivery order structure allows for phased deployment and testing.
NIH's established procurement processes likely mitigate some execution risks.

Sector Analysis

The market for analytical laboratory instrument manufacturing is a specialized segment within the broader healthcare technology sector. This contract falls under the production of equipment used for scientific analysis, particularly in biological and medical research. The global market for laboratory automation is growing, driven by the need for increased efficiency, accuracy, and throughput in research and diagnostic settings. NIH's spending in this area is consistent with its mission to advance scientific knowledge and improve health.

Small Business Impact

The provided data does not indicate any specific small business set-aside provisions for this contract, nor does it mention subcontracting goals. Given the specialized nature of advanced laboratory automation, it is possible that the primary contractor, Abbott Laboratories, is a large business. Further analysis would be needed to determine if small businesses are involved in the supply chain or as potential subcontractors for components or services related to this contract.

Oversight & Accountability

Oversight for this contract will likely be managed by the contracting officer and program officials within the National Institutes of Health (NIH). The firm fixed-price contract structure provides a degree of accountability by tying payment to delivery of specified goods. Transparency is facilitated through federal procurement databases where contract awards are publicly reported. The Inspector General's office for the Department of Health and Human Services may conduct audits or investigations if performance issues or potential fraud are identified.

Related Government Programs

NIH Research Grants
Clinical Laboratory Improvement Amendments (CLIA)
Federal Supply Schedule (FSS) for Medical Equipment
Biomedical Research and Development

Risk Flags

Potential for vendor lock-in
Integration complexity with existing systems
Training and adoption challenges for staff
Reliance on single manufacturer for critical equipment

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $4.2 million to ABBOTT LABORATORIES INC.. ABBOTT LABORATORY FRONT-END SPECIMEN AUTOMATION.

Who is the contractor on this award?

The obligated recipient is ABBOTT LABORATORIES INC..

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (National Institutes of Health).

What is the total obligated amount?

The obligated amount is $4.2 million.

What is the period of performance?

Start: 2024-05-01. End: 2027-04-30.

What is the track record of Abbott Laboratories with federal agencies, particularly NIH, for similar automation systems?

Abbott Laboratories has a significant history of supplying medical devices and laboratory equipment to federal agencies, including NIH. Their experience spans various product lines, including diagnostic instruments and automation solutions. While specific details on past performance for this exact type of specimen automation system with NIH are not detailed here, Abbott is a major player in the clinical diagnostics market. Federal procurement records would show the extent and nature of their previous contracts, including delivery performance, quality of goods, and adherence to contract terms. A review of past performance evaluations (e.g., Contractor Performance Assessment Reporting System - CPARS) would provide a more granular understanding of their reliability and success in fulfilling government requirements.

How does the $4.2 million cost compare to similar specimen automation systems procured by other federal agencies or large research institutions?

Benchmarking the $4.2 million cost requires comparing it against procurements of similar scale, complexity, and functionality. Factors influencing price include the degree of automation, throughput capacity, integration capabilities with laboratory information systems (LIS), software features, and service/maintenance agreements. Without specific details on the system's technical specifications and the number of bidders, a precise comparison is difficult. However, advanced laboratory automation systems can range from hundreds of thousands to several million dollars. Federal procurement databases (like FPDS or SAM.gov) can be queried for comparable contracts awarded to other agencies or institutions for similar equipment. If this contract involved a competitive process with multiple bids, the awarded price likely reflects market rates. If it was a sole-source or limited competition, further scrutiny of the pricing justification would be warranted.

What are the primary risks associated with implementing new specimen automation technology in a federal research laboratory setting?

Key risks include technical integration challenges, where the new system may not seamlessly interface with existing laboratory information systems (LIS) or other analytical instruments, leading to data silos or workflow disruptions. There's also the risk of operational disruption during the transition period, potentially impacting research timelines. Staff training and adoption are critical; inadequate training can lead to errors, underutilization of the system's capabilities, or safety concerns. Furthermore, reliance on a single vendor for maintenance and support (vendor lock-in) can lead to higher long-term costs and reduced flexibility. Finally, the system's performance might not meet the initially projected efficiency gains or accuracy improvements, impacting the return on investment and overall laboratory productivity.

What is the expected impact of this automation on the NIH's research output and efficiency?

The implementation of this front-end specimen automation system is expected to significantly enhance the efficiency and throughput of NIH laboratories. By automating tasks such as sample sorting, aliquoting, and preparation, the system aims to reduce manual labor, minimize human error, and accelerate the processing of biological samples. This increased speed and accuracy can lead to faster turnaround times for experiments and diagnostic tests, thereby accelerating the pace of research discovery. Improved workflow efficiency allows researchers and technicians to focus on higher-value analytical tasks rather than repetitive manual processes. Ultimately, this should contribute to a greater volume of reliable research data, potentially leading to quicker advancements in understanding and treating diseases.

How does this contract align with broader federal initiatives related to healthcare modernization and technological advancement?

This contract aligns with broader federal initiatives focused on modernizing healthcare infrastructure and leveraging technology to improve efficiency and outcomes. Agencies like NIH are tasked with advancing biomedical research, and investing in state-of-the-art laboratory automation is crucial for maintaining a competitive edge in scientific discovery. It supports goals related to digital transformation within government, enhancing data integrity, and improving the speed at which research findings can be translated into clinical applications. Furthermore, by adopting advanced automation, NIH demonstrates a commitment to utilizing cutting-edge technologies, which can serve as a model for other federal health agencies and contribute to the overall technological advancement within the U.S. healthcare ecosystem.

Industry Classification

NAICS: Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Analytical Laboratory Instrument Manufacturing

Product/Service Code: INSTRUMENTS AND LABORATORY EQPT

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY

Offers Received: 1

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Address: 100 ABBOTT PARK RD DEPT 943 BLDG AP6C-3, NORTH CHICAGO, IL, 60064

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $4,217,188

Exercised Options: $4,217,188

Current Obligation: $4,217,188

Actual Outlays: $2,076,951

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Parent Contract

Parent Award PIID: 36F79719D0024

IDV Type: FSS

Timeline